The UC Cancer Consortium
Five of the nation’s leading comprehensive cancer centers, have joined forces to form the University of California Cancer Consortium, part of UC Health. Each comprehensive cancer center treats all types of cancers in adults and children.
UC Davis Comprehensive Cancer Center
UC San Francisco Helen Diller Family Comprehensive Cancer Center
UCLA Jonsson Comprehensive Cancer Center
UCI Health Chao Family Comprehensive Cancer Center
UC San Diego Moores Cancer Center
Individually, these comprehensive cancer centers are hubs of expertise and innovation, advancing the development of technology, protocols, and medicines that will become available to practitioners and patients around the world.
Combined, the UC Cancer Consortium administers more than a thousand clinical trials annually, connects more than tens of thousands of patients to the newest, most innovative therapies available, and works to accelerate the most promising therapies forward toward federal approval.
Collectively, the Consortium’s cancer centers are the nation’s top recipient of research grants from the National Institutes of Health (NIH) and of cancer research grants from the National Cancer Institute (NCI), as well as the largest university holder of U.S. biomedical patents.
Find a clinical trial occurring at UC Health cancer centers
Use our Clinical Trial finder to see trials at all five of UC Health's NCI-designated comprehensive cancer centers. Each trial lists its unique criteria for participation. If you believe you meet the eligibility criteria, you can contact the research team to express interest.
Why Choose the UC Cancer Consortium for Your Care
Where you go for cancer treatment can make a significant difference in your health care experience and outcome. The five NCI-designed comprehensive cancer centers of the University of California bring many of the world’s top experts together for ground-breaking research, clinical trials and advanced patient care treatments.
Nearly half of the patients seen at a UC cancer center have late-stage cancers. These include patients diagnosed for the first time at a UC cancer center as well as patients diagnosed elsewhere and referred by physicians to UC for specialized care. Cancer centers that achieve the NCI comprehensive cancer center designation frequently see patients with rare and difficult cancers who cannot be treated in other hospitals due to a lack of specific expertise or clinical trials involving the latest experimental drugs.
The Prevalence of Cancer in California
More than 1.4 million California residents are living with a history of cancer, and 60% are living five years and beyond after a diagnosis. Despite these and other promising trends, nearly one out of every two Californians will develop cancer, and an estimated one in five will die of the disease.
California’s population of nearly 40 million people is one of the most ethnically diverse in the country. That diversity, combined with a large population living below the poverty line, pose challenges in ensuring that all residents have access to consistent, high-quality care. The UC Cancer Consortium views these and other barriers as an opportunity to advance clinical knowledge about all cancer types and stages, gain insights about disparities in access, improve health outcomes for all and advocate for patients at the local, state and national levels about access, quality, cost, and public health.
Learn more about cancer prevalence, trends and forecasts in California through these charts.